There is no evidence to support the use of beta2-agonists in children and adults with acute cough who do not have evidence of airﬂow restriction, a Cochrane review concludes. The analysis of seven trials by Cochrane Acute Respiratory Infections Group noted that treatment might reduce symptoms, including cough. However the potential beneﬁts were not well ...
Already a member?
Enter your email to keep reading.